Updates in CAR T Therapy for Multiple Myeloma.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 283
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2020 AND VI 34 AND IP 7
Results: 16
1
2
Telemedicine Use in Oncology Practices.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 280, doi. 10.46883/onc.2020.3407.0280
- By:
- Publication type:
- Article
3
Immunotherapy in Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 272, doi. 10.46883/onc.2020.3407.0272
- By:
- Publication type:
- Article
4
Emotional Distress During the COVID-19 Pandemic: Psycho-Oncology Perspective.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 270, doi. 10.46883/onc.2020.3407.0270
- By:
- Publication type:
- Article
5
COVID-19 and Malpractice: New Risks to Watch For.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 270A
- Publication type:
- Article
6
Oncology Clinical Trials During the COVID-19 Pandemic.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 265, doi. 10.46883/onc.2020.3407.0265
- By:
- Publication type:
- Article
7
Interim Phase 2 ZUMA-5 Results Show Promise for Axi-Cel in R/R iNHL.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 260
- By:
- Publication type:
- Article
8
Carfilzomib Triplet Fails to Induce Superior PFS in Newly Diagnosed Multiple Myeloma.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 258
- By:
- Publication type:
- Article
9
Final Data Analysis Supports Tivozanib as Superior Treatment for Patients With RCC.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 257
- By:
- Publication type:
- Article
10
Gastrointestinal Cancer Presentations Relevant to Clinical Practice.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 255, doi. 10.46883/onc.2020.3407.0255
- By:
- Publication type:
- Article
11
Nivolumab/Ipilimumab Combo Yields Durable Efficacy in Advanced NSCLC.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 254
- By:
- Publication type:
- Article
12
Phase 3 HERO Trial Finds Relugolix to Be Superior to Leuprolide in Prostate Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 252
- By:
- Publication type:
- Article
13
Mirvetuximab Soravtansine Combination Yields Encouraging Response Rates in Ovarian Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 250
- By:
- Publication type:
- Article
14
Cancer Progression Is Linked to Increased Risk of Death Within 30 Days of COVID-19 Diagnosis.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 249
- By:
- Publication type:
- Article
15
COVID-19 Pandemic and Its Effects on Cancer Care, Both Good and Bad.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 244, doi. 10.46883/onc.2020.3407.0244
- By:
- Publication type:
- Article
16
Forging Ahead in the COVID-19 era.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 7, p. 242
- By:
- Publication type:
- Article